Variant Synonymizer: Platform to identify mutations defined in different ways is available now!
Over 2,000 gene–disease validation summaries are now available—no login required!
Two unrelated patients with Cantú syndrome harbor de novo heterozygous missense variants in KCNJ8, in the absence of ABCC9 mutations. Patient 1 carried c.193G>A (p.Val65Met) and Patient 2 carried c.526T>A (p.Cys176Ser), both presenting hypertrichosis, macrosomia, osteochondrodysplasia, macrocephaly, coarse facial features, and cardiomegaly (PMID:24176758; PMID:24700710). No additional affected relatives were reported, and both variants were confirmed absent in ABCC9‐negative Cantú syndrome cohorts.
Functional assays of the Kir6.1[p.Cys176Ser] variant coexpressed with SUR1 or SUR2A demonstrate a significant gain of channel function due to reduced ATP inhibition, recapitulating the pathophysiology of Cantú syndrome and corroborating a dominant‐active mechanism (PMID:24700710). There are no published reports contradicting KCNJ8’s role in this phenotype.
Key take-home: Heterozygous gain-of-function KCNJ8 mutations cause autosomal dominant Cantú syndrome and should be included in diagnostic genetic testing panels.
Gene–Disease AssociationLimitedTwo unrelated de novo missense variants in KCNJ8 in Cantú syndrome probands ([PMID:24176758]; [PMID:24700710]); no segregation data. Genetic EvidenceLimited2 de novo heterozygous variants in unrelated individuals; absence of ABCC9 mutations. Functional EvidenceModerateKir6.1[p.Cys176Ser] channels exhibit gain-of-function with reduced ATP sensitivity in patch-clamp studies ([PMID:24700710]). |